Advances in colon capsule endoscopy: a review of current applications and challenges
Frontiers in Gastroenterology · 17.11.2023 · 2
DOI: 10.3389/fgstr.2023.1316334 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 17.11.2023. Verfasst von E Gibbons und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Connolly Hospital, Dublin, Ireland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colon capsule endoscopy (CCE) has been demonstrated to be comparable to traditional colonoscopy and better than CT colonography (CTC) for the detection of colonic pathology. It has been shown to have a high incremental yield after incomplete colonoscopy. It is a safe test with good patient acceptability. Challenges currently include great variability in completion rates and high rates of re-investigation. In this review, we will discuss the evidence to date regarding CCE in symptomatic and surveillance populations, and in those post incomplete colonoscopy. We will discuss current challenges faced by CCE and areas for further research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology Department, Connolly Hospital, Dublin, Ireland.
Zitieren
APA
Gibbons, E., Kelly, O. B., & Hall, B. (2023). Advances in colon capsule endoscopy: a review of current applications and challenges. Frontiers in Gastroenterology, 2. https://doi.org/10.3389/fgstr.2023.1316334
Vancouver
Gibbons E, Kelly OB, Hall B. Advances in colon capsule endoscopy: a review of current applications and challenges. Frontiers in Gastroenterology. 2023;2. doi:10.3389/fgstr.2023.1316334
BibTeX
@article{Gibbons2023,
author = {Gibbons, E and Kelly, O B and Hall, B},
title = {Advances in colon capsule endoscopy: a review of current applications and challenges},
journal = {Frontiers in Gastroenterology},
year = {2023},
volume = {2},
doi = {10.3389/fgstr.2023.1316334}
}
EUVIMED